HomeBLEL › Filing
🔔 Get instant alerts when BLEL files quarterly results on BSE Start free trial →

General Updates

Filed: 08 Sep 2026, 14:40 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1 FY27 - Revenue 151.7 Cr +18.0% y-y; EBITDA 29.7 Cr (margin 19.6%, +85 bps y-y); PAT 19.2 Cr +24.5% y-y - Sales volume 22,095 MT, +13.4% y-y; EBITDA per MT Rs. 13,457, +8.8% y-y - High-value products share rose to 60.4% of revenue in Q1 FY27 from 57.78% in FY26 - Order book Rs. 162 Cr as of June 30, 2026, providing healthy revenue visibility - IPO subscribed 108.44x; fresh issue proceeds Rs. 93 Cr to fund capacity expansion - Balance sheet strong with net worth Rs. 325 Cr, debt to equity 0.03x, cash Rs. 52 Cr - Capacity utilization at 90.5% in Q1 FY27; venturing into defence and aerospace sectors
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 BLEL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add BLEL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Behari Lal Engineering Limited

Important. The summary above is generated automatically from Behari Lal Engineering Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.